Cargando…

Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia

BACKGROUND: The criteria for PD‐MCI allow the use of global cognitive tests. Their predictive value for conversion from PD‐MCI to PDD, especially compared to comprehensive neuropsychological assessment, is unknown. METHODS: The MDS PD‐MCI Study Group combined four datasets containing global cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boel, Judith A., de Bie, Rob M.A., Schmand, Ben A., Dalrymple‐Alford, John C., Marras, Connie, Adler, Charles H., Goldman, Jennifer G., Tröster, Alexander I., Burn, David J., Litvan, Irene, Geurtsen, Gert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092740/ https://www.ncbi.nlm.nih.gov/pubmed/35582313 http://dx.doi.org/10.1002/mdc3.13451

Ejemplares similares

Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
por: Wood, Kyla-Louise, et al.
Publicado: (2016)

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
por: Jones, Ann J., et al.
Publicado: (2017)

Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors
por: Gonzalez-Latapi, Paulina, et al.
Publicado: (2021)

Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge
por: Cammisuli, Davide Maria, et al.
Publicado: (2019)

Potential Benefits of Physical Activity in MCI and Dementia
por: Nuzum, Hallie, et al.
Publicado: (2020)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort
por: Lawson, Rachael A., et al.
Publicado: (2021)

Short IQCODE as a screening tool for MCI and dementia: Preliminary results
por: Perroco, Tíbor Rilho, et al.
Publicado: (2008)

QEEG- BRAIN MAPPING - A biomarker to predict MCI/ Dementia.
por: Murugappan, SP., et al.
Publicado: (2022)

MACE for Diagnosis of Dementia and MCI: Examining Cut-Offs and Predictive Values
por: Larner, Andrew J.
Publicado: (2019)

Identification of dementia and MCI cases in health information systems: An Italian validation study
por: Bacigalupo, Ilaria, et al.
Publicado: (2022)

Association of Cerebral Ischemia With Corneal Nerve Loss and Brain Atrophy in MCI and Dementia
por: Ponirakis, Georgios, et al.
Publicado: (2021)

Mild cognitive impairment (MCI) and dementia in a sample of adults in the city of Bogotá
por: Pedraza, Olga Lucia, et al.
Publicado: (2017)

Codex (Cognitive Disorders Examination) Decision Tree Modified for the Detection of Dementia and MCI
por: Ziso, Besa, et al.
Publicado: (2019)

THE ASSOCIATION OF FRAILTY WITH MCI AND DEMENTIA IN A MEMORY DISORDERS CLINIC FOR OLDER VETERANS
por: Shah, Aakashi, et al.
Publicado: (2019)

Epidemiological Evidence for an Immune Component of Parkinson’s Disease
por: Gonzalez-Latapi, Paulina, et al.
Publicado: (2022)

NIMHANS Neuropsychological Battery for Elderly in Parkinson’s Disease Patients: Validation and Diagnosis using MDS PD-MCI Task Force Criteria in Indian Population
por: Botta, Ragasudha, et al.
Publicado: (2023)

The protocol of a clinical quality registry for dementia and mild cognitive impairment (MCI): the Australian dementia network (ADNeT) Registry
por: Lin, Xiaoping, et al.
Publicado: (2020)

Dual Sensory Impairment and Cognitive Performance, MCI, and Dementia in Older Adults: The ARIC Neurocognitive Study
por: Deal, Jennifer, et al.
Publicado: (2020)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2023)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

Lack of Correlation of WAIS Digit Span with Clox 1 and the Dementia Rating Scale in MCI
por: Lortie, Jevin Jay, et al.
Publicado: (2012)

Multi‐time‐point data preparation robustly reveals MCI and dementia risk factors
por: Kaur, Daman, et al.
Publicado: (2020)

Decreasing Social Support Associated With Risk of MCI and Dementia Is Partially Mediated by Hippocampal Volume
por: Gruenewald, Tara, et al.
Publicado: (2020)

Qualitative Study of an mHealth Mindfulness intervention with Caregivers of Older Adults with MCI or Dementia
por: Llaneza, Danielle, et al.
Publicado: (2021)

Preliminary Efficacy of an mHealth Mindfulness Intervention With Caregivers of Older Adults With MCI or Dementia
por: Kozlov, Elissa, et al.
Publicado: (2021)

Motor and Sensory Function as Predictors of MCI and Dementia in the Baltimore Longitudinal Study of Aging (BLSA)
por: Schrack, Jennifer, et al.
Publicado: (2021)

Optimal MoCA cutoffs for detecting biologically-defined patients with MCI and early dementia
por: Ilardi, Ciro Rosario, et al.
Publicado: (2022)

PHOTOVOICE STUDY TO EXPLORE THE PHYSICAL DISABILITY EXPERIENCE IN OLDER ADULTS WITH MCI/EARLY DEMENTIA
por: Jenkins, Emerald, et al.
Publicado: (2022)

MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes
por: Bettcher, Brianne M., et al.
Publicado: (2016)

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
por: Lauterbach, Edward C.
Publicado: (2016)

Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
por: Naisby, J., et al.
Publicado: (2021)

22q11.2 Deletion Syndrome–Associated Parkinson's Disease
por: Boot, Erik, et al.
Publicado: (2018)

Examining older adults with neuroatypical conditions for MCI/dementia: Barriers and recommendations of the Neuroatypical Conditions Expert Consultative Panel
por: Janicki, Matthew P., et al.
Publicado: (2022)

Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up
por: van Mierlo, Tom J. M., et al.
Publicado: (2021)

System Development Guidelines From a Review of Motion-Based Technology for People With Dementia or MCI
por: Astell, Arlene J., et al.
Publicado: (2018)

The Newly Normed SKT Reveals Differences in Neuropsychological Profiles of Patients with MCI, Mild Dementia and Depression
por: Lehfeld, Hartmut, et al.
Publicado: (2019)

Medical Health Records-Based Mild Cognitive Impairment (MCI) Prediction for Effective Dementia Care
por: Lim, Soo-Jin, et al.
Publicado: (2021)

REMOTE ELECTRONIC DATA CAPTURE OF MEDICATION USE AND AGITATION SYMPTOMS IN OLDER ADULTS WITH MCI OR DEMENTIA
por: Au-Yeung, Wan-Tai, et al.
Publicado: (2022)

Resting-state fMRI markers of conversion to dementia in amnestic MCI: a pilot study
por: Abdullina, E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9mo11qmqak8jafq935qirkjkah